Avacta Expands Following Aptuscan Acquisition
News Jul 09, 2012
Avacta Group has expanded its Yorkshire headquarters with the addition of new laboratory, office and manufacturing space.
The move, which follows the recent acquisition of affinity reagents specialist Aptuscan, brings together the entire Avacta Group on the same site.
The new facilities, which include purpose built laboratories, are at Avacta’s existing Thorp Arch Estate premises in Wetherby, UK, and have been taken on to accommodate the Company’s current rapid expansion.
Alastair Smith, Chief Executive of Avacta, commented: “Our core businesses are seeing strong growth, and recent funding, together with the acquisition of Aptuscan, will ensure we are able to accelerate our existing product development pipeline. Thorp Arch Estate is an ideal location for biotechnology enterprises, with excellent transport connections, and we are enthusiastic about plans to create a wider science park facility here.”
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Evolution Threatens Efficient Bioproduction Scale-UpNews
The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.